Journal article · 2018 · Open access
CD8+ lymphocyte control of SIV infection during antiretroviral therapy
PLoS Pathogens, 14(10), e1007350 · Published 11 October 2018 · DOI 10.1371/journal.ppat.1007350
In brief
“CD8+ lymphocyte control of SIV infection during antiretroviral therapy” is a 2018 journal article by Youfang Cao and 3 co-authors, published in PLoS Pathogens. OpenAlex counts 31 citations as of 19 November 2026. It is open access under a public domain licence: the full text is free to read at PLoS Pathogens.
- Citations
- 31
- Most cited in
- 2019 (7)
- Field-weighted impact
- 1.88
- References
- 45
- Authors
- 4
Abstract
CD8+ lymphocytes play an important role in suppressing in vivo viral replication in HIV infection. However, both the extent to which and the mechanisms by which CD8+ lymphocytes contribute to viral control are not completely understood. A recent experiment depleted CD8+ lymphocytes in simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs) on antiretroviral treatment (ART) to study the role of CD8+ lymphocytes. CD8+ lymphocytes depletion resulted in temporary plasma viremia in all studied RMs. Viral control was restored when CD8+ lymphocytes repopulated. We developed a viral dynamic model to fit the viral load (VL) data from the CD8 depletion experiment. We explicitly modeled the dynamics of the latent reservoir and the SIV-specific effector cell population including their exhaustion and their potential cytolytic and noncytolytic functions. We found that the latent reservoir significantly contributes to the size of the peak VL after CD8 depletion, while drug efficacy plays a lesser role. Our model suggests that the overall CD8+ lymphocyte cytolytic killing rate is dynamically changing depending on the levels of antigen-induced effector cell activation and exhaustion. Based on estimated parameters, our model suggests that before ART or without ART the overall CD8 cytolytic killing rate is small due to exhaustion. However, after the start of ART, the overall CD8 cytolytic killing rate increases due to an expansion of SIV-specific CD8 effector cells. Further, we estimate that the cytolytic killing rate can be significantly larger than the cytopathic death rate in some animals during the second phase of ART-induced viral decay. Lastly, our model provides a new explanation for the puzzling findings by Klatt et al. and Wong et al. that CD8 depletion done immediately before ART has no noticeable effect on the first phase viral decay slope seen after ART initiation Overall, by incorporating effector cells and their exhaustion, our model can explain the effects of CD8 depletion on VL during ART, reveals a detailed dynamic role of CD8+ lymphocytes in controlling viral infection, and provides a unified explanation for CD8 depletion experimental data.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Cao, Y., Cartwright, E. K., Silvestri, G., & Perelson, A. S. (2018). CD8+ lymphocyte control of SIV infection during antiretroviral therapy. PLoS Pathogens, 14(10), e1007350. https://doi.org/10.1371/journal.ppat.1007350
MLA 9
Cao, Youfang, et al. “CD8+ lymphocyte control of SIV infection during antiretroviral therapy.” PLoS Pathogens, vol. 14, no. 10, 2018, p. e1007350. https://doi.org/10.1371/journal.ppat.1007350.
Chicago
Cao, Youfang, Emily Kathleen Cartwright, Guido Silvestri, and Alan S. Perelson. 2018. “CD8+ lymphocyte control of SIV infection during antiretroviral therapy.” PLoS Pathogens 14 (10): e1007350. https://doi.org/10.1371/journal.ppat.1007350.
Harvard
Cao, Y. et al. (2018) ‘CD8+ lymphocyte control of SIV infection during antiretroviral therapy’, PLoS Pathogens, 14(10), p. e1007350. doi:10.1371/journal.ppat.1007350.
IEEE
Y. Cao, E. K. Cartwright, G. Silvestri, and A. S. Perelson, “CD8+ lymphocyte control of SIV infection during antiretroviral therapy,” PLoS Pathogens, vol. 14, no. 10, p. e1007350, 2018, doi: 10.1371/journal.ppat.1007350.
BibTeX
@article{cao2018lymphocyte,
title = {{CD8+ lymphocyte control of SIV infection during antiretroviral therapy}},
author = {Cao, Youfang and Cartwright, Emily Kathleen and Silvestri, Guido and Perelson, Alan S.},
journal = {PLoS Pathogens},
year = {2018},
volume = {14},
number = {10},
pages = {e1007350},
doi = {10.1371/journal.ppat.1007350},
url = {https://doi.org/10.1371/journal.ppat.1007350}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 1 | |
| 2019 | 7 | |
| 2020 | 2 | |
| 2021 | 7 | |
| 2022 | 1 | |
| 2023 | 2 | |
| 2024 | 7 | |
| 2025 | 1 | |
| 2026 | 3 |
Its field-weighted citation impact is 1.88: it has been cited 1.88 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- CD8+ T cells
- simian immunodeficiency virus
- rhesus monkeys
- antiretroviral therapy
- CD8 depletion
- viral dynamics model
- latent viral reservoir
- T cell exhaustion
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Cao, Y., Cartwright, E. K., Silvestri, G., & Perelson, A. S. (2018). CD8+ lymphocyte control of SIV infection during antiretroviral therapy. PLoS Pathogens, 14(10), e1007350. https://doi.org/10.1371/journal.ppat.1007350
How many times has this paper been cited?
31 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PLoS Pathogens: sign in and open the PDF from this page.
Who wrote this paper?
Youfang Cao, Emily Kathleen Cartwright, Guido Silvestri, Alan S. Perelson.
What is the DOI of this paper?
10.1371/journal.ppat.1007350, permanently at https://doi.org/10.1371/journal.ppat.1007350. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.